CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in AVIR — Atea Pharmaceuticals, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in AVIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,839,322
-$370,972 QoQ
Shares Held
610,607
+2.3% QoQ
Ownership
0.761%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 124 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. AVIR ranks #167 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in AVIR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,839,322 | 610,607 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,210,294 | 596,709 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,169,817 | 607,792 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,812,453 | 624,984 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,287,015 | 635,282 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $2,209,415 | 659,527 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,178,025 | 650,157 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,983,891 | 599,363 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,473,768 | 612,319 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,782,194 | 584,326 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,746,699 | 582,233 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,146,606 | 573,959 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,763,269 | 526,349 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,715,216 | 564,494 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,148,413 | 553,324 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,036,819 | 427,721 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,993,390 | 414,597 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,533,508 | 395,247 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,784,855 | 393,179 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $4,217,361 | 196,339 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,485,870 | 88,840 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,611,212 | 86,434 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||